Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Change in Account Payables (2016 - 2025)

China Pharma Holdings filings provide 16 years of Change in Account Payables readings, the most recent being $292259.0 for Q4 2025.

  • On a quarterly basis, Change in Account Payables rose 287.64% to $292259.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $650309.0, a 188.61% increase, with the full-year FY2025 number at $650309.0, up 188.61% from a year prior.
  • Change in Account Payables hit $292259.0 in Q4 2025 for China Pharma Holdings, up from $54437.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $442807.0 in Q3 2023 to a low of -$505339.0 in Q2 2024.
  • Median Change in Account Payables over the past 5 years was $25512.0 (2022), compared with a mean of -$14603.8.
  • Biggest five-year swings in Change in Account Payables: skyrocketed 3045.77% in 2023 and later tumbled 414.87% in 2024.
  • China Pharma Holdings' Change in Account Payables stood at $311018.0 in 2021, then dropped by 23.32% to $238485.0 in 2022, then crashed by 54.75% to $107922.0 in 2023, then plummeted by 244.32% to -$155753.0 in 2024, then soared by 287.64% to $292259.0 in 2025.
  • The last three reported values for Change in Account Payables were $292259.0 (Q4 2025), $54437.0 (Q3 2025), and -$19322.0 (Q2 2025) per Business Quant data.